A detailed history of Sectoral Asset Management Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Sectoral Asset Management Inc holds 36,870 shares of BMRN stock, worth $2.46 Million. This represents 2.16% of its overall portfolio holdings.

Number of Shares
36,870
Previous 41,260 10.64%
Holding current value
$2.46 Million
Previous $3.4 Million 23.7%
% of portfolio
2.16%
Previous 1.69%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$69.02 - $93.84 $302,997 - $411,957
-4,390 Reduced 10.64%
36,870 $2.59 Million
Q2 2024

Aug 13, 2024

SELL
$74.43 - $92.22 $772,583 - $957,243
-10,380 Reduced 20.1%
41,260 $3.4 Million
Q1 2024

May 14, 2024

BUY
$83.81 - $99.0 $131,581 - $155,430
1,570 Added 3.14%
51,640 $4.51 Million
Q4 2023

Feb 14, 2024

SELL
$76.22 - $98.51 $7.24 Million - $9.36 Million
-95,020 Reduced 65.49%
50,070 $4.83 Million
Q3 2023

Nov 14, 2023

SELL
$85.07 - $94.48 $285,665 - $317,263
-3,358 Reduced 2.26%
145,090 $12.8 Million
Q2 2023

Aug 11, 2023

BUY
$86.68 - $100.3 $2.08 Million - $2.41 Million
24,018 Added 19.3%
148,448 $12.9 Million
Q1 2023

May 12, 2023

SELL
$87.74 - $117.27 $1.26 Million - $1.68 Million
-14,350 Reduced 10.34%
124,430 $12.1 Million
Q4 2022

Feb 10, 2023

SELL
$80.93 - $108.63 $1.98 Million - $2.66 Million
-24,450 Reduced 14.98%
138,780 $14.4 Million
Q3 2022

Nov 10, 2022

BUY
$82.16 - $96.94 $1.77 Million - $2.08 Million
21,500 Added 15.17%
163,230 $13.8 Million
Q2 2022

Aug 15, 2022

BUY
$71.48 - $86.85 $2.62 Million - $3.18 Million
36,600 Added 34.81%
141,730 $11.7 Million
Q1 2022

May 10, 2022

BUY
$74.28 - $92.69 $7.06 Million - $8.81 Million
95,000 Added 937.81%
105,130 $8.11 Million
Q4 2021

Feb 11, 2022

SELL
$71.72 - $91.47 $6.88 Million - $8.78 Million
-95,982 Reduced 90.45%
10,130 $895,000
Q3 2021

Nov 15, 2021

BUY
$74.77 - $85.47 $2.5 Million - $2.85 Million
33,390 Added 45.91%
106,112 $8.2 Million
Q2 2021

Aug 16, 2021

SELL
$75.51 - $84.79 $1.11 Million - $1.25 Million
-14,750 Reduced 16.86%
72,722 $6.07 Million
Q1 2021

May 14, 2021

SELL
$74.73 - $90.69 $694,989 - $843,417
-9,300 Reduced 9.61%
87,472 $6.61 Million
Q4 2020

Feb 12, 2021

SELL
$72.61 - $90.2 $3.96 Million - $4.92 Million
-54,550 Reduced 36.05%
96,772 $8.49 Million
Q3 2020

Nov 13, 2020

BUY
$71.87 - $131.03 $1.42 Million - $2.58 Million
19,699 Added 14.97%
151,322 $11.5 Million
Q2 2020

Aug 13, 2020

SELL
$79.55 - $124.22 $4.17 Million - $6.51 Million
-52,388 Reduced 28.47%
131,623 $16.2 Million
Q1 2020

May 13, 2020

SELL
$71.37 - $96.85 $2.85 Million - $3.86 Million
-39,890 Reduced 17.82%
184,011 $15.5 Million
Q4 2019

Feb 12, 2020

BUY
$64.27 - $86.37 $5.28 Million - $7.09 Million
82,100 Added 57.9%
223,901 $18.9 Million
Q3 2019

Nov 14, 2019

SELL
$67.4 - $85.11 $761,620 - $961,743
-11,300 Reduced 7.38%
141,801 $9.56 Million
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $5.85 Million - $6.83 Million
72,780 Added 90.61%
153,101 $13.1 Million
Q1 2019

May 14, 2019

SELL
$84.2 - $98.62 $951,460 - $1.11 Million
-11,300 Reduced 12.33%
80,321 $7.14 Million
Q4 2018

Feb 12, 2019

SELL
$80.14 - $106.07 $7.46 Million - $9.87 Million
-93,074 Reduced 50.39%
91,621 $7.8 Million
Q3 2018

Nov 14, 2018

SELL
$93.92 - $105.72 $7.12 Million - $8.01 Million
-75,810 Reduced 29.1%
184,695 $17.9 Million
Q2 2018

Aug 13, 2018

SELL
$76.01 - $99.03 $10.4 Million - $13.6 Million
-137,398 Reduced 34.53%
260,505 $24.5 Million
Q1 2018

May 15, 2018

BUY
$77.67 - $92.63 $10.8 Million - $12.9 Million
139,400 Added 53.93%
397,903 $32.3 Million
Q4 2017

Feb 13, 2018

BUY
$80.76 - $95.13 $1.62 Million - $1.91 Million
20,090 Added 8.43%
258,503 $23.1 Million
Q3 2017

Nov 14, 2017

BUY
$80.6 - $94.95 $19.2 Million - $22.6 Million
238,413
238,413 $22.2 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.